Open an account

Sanofi SA

SNY · NYSE

$41.60−$0.36 (−0.86%)TodayMarket closed ·
Prev close $41.96

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 76,493 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Employees
76,493
Headquarters
Paris, Ile-De-France
Listed
Jul 1, 2002
Sector
Health Care
Industry
Pharmaceuticals
Website
sanofi.com

SNY key statistics

Market cap
89.90B
Price-earnings ratio
5.61
Dividend yield
10.78%
Average volume
3.70M
Volume
2.01M
Open price
$41.70
High today
$41.75
Low today
$41.33
52 Week high
$52.68
52 Week low
$39.07

Sanofi SA (SNY) at a glance

As of Oct 23, 2026, Sanofi SA (SNY) shares are priced at $41.60, giving the company a market cap of 89.90B, a price-to-earnings ratio of 5.61 and a dividend yield of 10.78%.

Today the stock has traded between $41.33 and $41.75. The current price is 0.7% above the day's low and 0.4% below its high.

Volume so far is 2.01M shares, below the average of 3.70M shares a day.

Over the past year Sanofi SA has ranged from $39.07 to $52.68, and now sits 19% of the way up that range.

The average analyst price target is $52.08, 25.2% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

20%of 5 analyst ratings say Buy
  • Buy20.0%
  • Hold80.0%
  • Sell0.0%
Price target · 28 analystsAvg $52.08
Low
$32.06
Now
$41.60
High
$62.68

SNY news

  • Press releaseBusiness Wire

    ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics

  • Vandana Singh

    Novavax's Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push

  • Mohd Haider

    Recursion Pharmaceuticals (RXRX) Stock is Trending After Hours: Here’s What You Should Know

  • Vandana Singh

    Sanofi Must Set Record Straight on Rival Flu Shot Under EU Antitrust Deal

  • Press releasePRNewswire

    Sanofi and pCPA Sign Letter of Intent for Dupixent® Across Four Indications in Dermatology and Respiratory Care

  • Press releaseGlobe Newswire

    AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test

  • Press releasePRNewswire

    Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®

  • Vandana Singh

    Sanofi Deepens 20-Year Drug Development Pact With Regeneron, Pledges Up to $8 Billion

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.